发明名称 CRYSTALLINE FORM OF PYRIMIDO[6,1-A] ISOQUINOLIN-4-ONE COMPOUND
摘要 <p>The current invention is directed towards a polymorph of N-{2-[(2E)-2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]-isoquinolin-3(4H)-yl]ethyl}urea, in the form of a crystalline solid consisting of greater than 99% by weight of N-{2-[(2E)-2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]-isoquinolin-3(4H)-yl]ethyl}urea, at least 95% in the polymorphic form of a thermodynamically stable polymorph (I) of N-{2-[(2E)-2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]-isoquinolin-3(4H)-yl]ethyl}urea, wherein said polymorph is determined by single crystal X-ray structural analysis and X-ray powder diffraction pattern.</p>
申请公布号 EP2603509(B1) 申请公布日期 2014.06.18
申请号 EP20110748611 申请日期 2011.08.09
申请人 VERONA PHARMA PLC 发明人 WALKER, MICHAEL, J., A.;PLOUVIER, BERTRAND, M., C.;NORTHEN, JULIAN, S.;FERNANDES, PHILIPPE
分类号 C07D471/04;A61K31/519;A61P11/00 主分类号 C07D471/04
代理机构 代理人
主权项
地址